Signaling pathways for cardiac hypertrophy and failure.
暂无分享,去创建一个
K. Chien | J. Hunter | K R Chien | J J Hunter | J. J. Hunter
[1] J Ross,et al. Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family* , 1998, The Journal of Biological Chemistry.
[2] Jiahuai Han,et al. Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells* , 1998, The Journal of Biological Chemistry.
[3] K. Chien,et al. Genes and physiology: molecular physiology in genetically engineered animals. , 1996, The Journal of clinical investigation.
[4] Minoru Hongo,et al. MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.
[5] J Ross,et al. Molecular and physiological alterations in murine ventricular dysfunction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Chien,et al. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] K. Chien,et al. Complexity in simplicity: monogenic disorders and complex cardiomyopathies. , 1999, The Journal of clinical investigation.
[8] Frederick J. Schoen,et al. A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.
[9] K. Chien,et al. Stress Pathways and Heart Failure , 1999, Cell.
[10] J. Ross,et al. Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress , 1999, Cell.
[11] R. Lefkowitz,et al. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Heath,et al. Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy , 1996, The Journal of Biological Chemistry.
[13] J. Sadoshima,et al. Critical Role of the AT1 Receptor Subtype , 2005 .
[14] K. Chien,et al. Rho Is Required for Gαq and α1-Adrenergic Receptor Signaling in Cardiomyocytes , 1996, The Journal of Biological Chemistry.
[15] M. C. Lin,et al. Heart and lung disease in engineered mice , 1995, Nature Medicine.
[16] A. Means,et al. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. , 1993, Endocrinology.
[17] E. Lakatta,et al. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. , 1999, Circulation research.
[18] S. Vatner,et al. Adverse Effects of Chronic Endogenous Sympathetic Drive Induced by Cardiac Gsα Overexpression , 1996 .
[19] H. Nishi,et al. Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy. , 1998, Circulation research.
[20] E. Neer,et al. Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] G. Dorn,et al. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. , 1996, The Journal of clinical investigation.
[22] S. Powers,et al. HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. , 1993, The Journal of biological chemistry.
[23] John W. Adams,et al. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] T. Yamazaki,et al. Specific Interaction of Topoisomerase II and the CD3 Chain of the T Cell Receptor Complex (*) , 1996, The Journal of Biological Chemistry.
[25] K. Chien,et al. Transcriptional regulation during cardiac growth and development. , 1993, Annual review of physiology.
[26] D. Absher,et al. Gq- and ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following alpha 1-adrenergic stimulation. , 1994, The Journal of biological chemistry.
[27] Y. Hayashizaki,et al. Identification of the Syrian hamster cardiomyopathy gene. , 1997, Human Molecular Genetics.
[28] R. Lefkowitz,et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. , 1998, Science.
[29] K. Chien,et al. Targeting gene expression to specific cardiovascular cell types in transgenic mice. , 1993, Hypertension.
[30] J Ross,et al. Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Sadoshima,et al. The heterotrimeric G q protein‐coupled angiotensin II receptor activates p21 ras via the tyrosine kinase‐Shc‐Grb2‐Sos pathway in cardiac myocytes. , 1996, The EMBO journal.
[32] R. Lefkowitz,et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.
[33] R Aikawa,et al. Endothelin-1 Is Involved in Mechanical Stress-induced Cardiomyocyte Hypertrophy (*) , 1996, The Journal of Biological Chemistry.
[34] Jeffrey Robbins,et al. A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.
[35] G. Dorn,et al. Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .
[36] K. Chien,et al. Ventricular Expression of a MLC-2v-ras Fusion Gene Induces Cardiac Hypertrophy and Selective Diastolic Dysfunction in Transgenic Mice (*) , 1995, The Journal of Biological Chemistry.
[37] K. Chien,et al. Physiological assessment of complex cardiac phenotypes in genetically engineered mice. , 1997, The American journal of physiology.
[38] J. Ross,et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[39] R. Lefkowitz,et al. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995, Science.
[40] K. Chien,et al. Cardiotrophin 1 (CT-1) Inhibition of Cardiac Myocyte Apoptosis via a Mitogen-activated Protein Kinase-dependent Pathway , 1997, The Journal of Biological Chemistry.
[41] Michael E. Greenberg,et al. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.
[42] M. Shichiri,et al. Insulinlike Growth Factor‐I Induces Hypertrophy With Enhanced Expression of Muscle Specific Genes in Cultured Rat Cardiomyocytes , 1993, Circulation.
[43] J. Ross,et al. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. , 1995, The Journal of clinical investigation.
[44] M. Lohse,et al. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[45] K. Chien,et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. , 1990, The Journal of biological chemistry.
[46] T. Doetschman,et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. , 1994, Circulation research.
[47] K. Chien,et al. Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. , 1998, Development.
[48] J. Ross,et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy , 1991, Proceedings of the National Academy of Sciences of the United States of America.